Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $4,074 | 1 | 42.3% |
| Consulting Fee | $4,050 | 1 | 42.1% |
| Food and Beverage | $1,505 | 115 | 15.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Trice Medical, Inc. | $8,124 | 2 | $0 (2020) |
| ABBVIE INC. | $561.83 | 39 | $0 (2022) |
| Allergan Inc. | $194.20 | 27 | $0 (2018) |
| Gilead Sciences, Inc. | $164.40 | 8 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $137.63 | 13 | $0 (2019) |
| Intercept Pharmaceuticals, Inc. | $124.33 | 8 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $106.43 | 6 | $0 (2018) |
| Shionogi Inc | $50.59 | 3 | $0 (2020) |
| Braintree Laboratories, Inc. | $41.31 | 3 | $0 (2018) |
| UCB, Inc. | $36.16 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.48 | 1 | Boston Scientific Corporation ($17.48) |
| 2022 | $16.16 | 1 | ABBVIE INC. ($16.16) |
| 2021 | $87.18 | 5 | AbbVie Inc. ($73.41) |
| 2020 | $8,283 | 13 | Trice Medical, Inc. ($8,124) |
| 2019 | $160.27 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($37.29) |
| 2018 | $508.69 | 37 | AbbVie, Inc. ($160.61) |
| 2017 | $555.43 | 50 | Allergan Inc. ($169.24) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: General - Pain Management_NMD | ||||||
| 03/24/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/30/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/22/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/03/2021 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/13/2021 | Medtronic, Inc. | GI Genius (Device) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Gastrointestinal AI | ||||||
| 12/12/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/30/2020 | Trice Medical, Inc. | Segway blade or mieye camera (Device) | Travel and Lodging | Cash or cash equivalent | $4,073.50 | General |
| Category: orthopedic device | ||||||
| 11/17/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/03/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/03/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/05/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/15/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2020 | Trice Medical, Inc. | Segway blade or mieye camera (Device) | Consulting Fee | Cash or cash equivalent | $4,050.00 | General |
| Category: orthopedic device | ||||||
| 08/12/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/07/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/13/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.24 | General |
| 02/05/2020 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/21/2019 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 09/19/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.84 | General |
| 08/27/2019 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 07/09/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 02/06/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 179 | 182 | $144,985 | $23,147 |
| 2021 | 9 | 337 | 377 | $129,644 | $35,453 |
| 2020 | 9 | 287 | 323 | $114,998 | $29,479 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 39 | 39 | $52,221 | $8,099 | 15.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 43 | 43 | $45,150 | $4,512 | 10.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 33 | 34 | $25,704 | $3,105 | 12.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 13 | 13 | $7,631 | $2,290 | 30.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 12 | 12 | $6,120 | $2,133 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 16 | $2,856 | $1,140 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,089 | $1,120 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 14 | $2,214 | $748.58 | 33.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 82 | 111 | $16,206 | $7,503 | 46.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 63 | $16,128 | $5,403 | 33.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 43 | 43 | $14,750 | $5,126 | 34.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 21 | 21 | $16,086 | $3,852 | 23.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 51 | 51 | $20,400 | $3,665 | 18.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 30 | 30 | $24,000 | $3,598 | 15.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 17 | 17 | $14,450 | $3,419 | 23.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 22 | 22 | $4,774 | $1,855 | 38.9% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 19 | 19 | $2,850 | $1,032 | 36.2% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 37 | 37 | $29,600 | $5,711 | 19.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 59 | $14,304 | $4,909 | 34.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 43 | 43 | $14,190 | $4,863 | 34.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 57 | 77 | $11,242 | $3,777 | 33.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 46 | 47 | $18,800 | $3,182 | 16.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 15 | 15 | $11,490 | $2,665 | 23.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 12 | 12 | $9,216 | $2,250 | 24.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 18 | 18 | $3,906 | $1,360 | 34.8% |
About Dr. Ryan Fauble, MD
Dr. Ryan Fauble, MD is a Gastroenterology healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427170166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Fauble, MD has received a total of $9,628 in payments from pharmaceutical and medical device companies, with $17.48 received in 2024. These payments were reported across 117 transactions from 15 companies. The most common payment nature is "Travel and Lodging" ($4,074).
As a Medicare-enrolled provider, Fauble has provided services to 803 Medicare beneficiaries, totaling 882 services with total Medicare billing of $88,079. Data is available for 3 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Ann Arbor, MI
- Active Since 04/04/2007
- Last Updated 04/07/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1427170166
Products in Payments
- Segway blade or mieye camera (Device) $8,124
- LINZESS (Drug) $236.45
- Creon (Drug) $202.11
- Humira (Biological) $120.12
- VIBERZI (Drug) $106.88
- Trulance (Drug) $106.43
- Amitiza (Drug) $99.29
- OCA (Drug) $79.46
- Mulpleta (Drug) $50.59
- OCALIVA (Drug) $44.87
- SUPREP (Drug) $41.31
- Cimzia (Drug) $36.16
- Dexilant (Drug) $29.96
- XELJANZ (Drug) $26.55
- HUMIRA (Biological) $23.92
- Mavyret (Drug) $23.64
- CREON (Drug) $23.45
- RINVOQ (Biological) $16.16
- XIFAXAN (Drug) $15.71
- PillCam (Device) $14.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Ann Arbor
Peter Higgins, Md, Phd, MD, PHD
Gastroenterology — Payments: $159,080
Elliot Tapper, M.d, M.D
Gastroenterology — Payments: $144,840
Dr. Eric Shah, M.d., M.b.a, M.D., M.B.A
Gastroenterology — Payments: $56,397
Mr. Shrinivas Bishu, M.d, M.D
Gastroenterology — Payments: $18,410
Jeffrey Berinstein, Md, MD
Gastroenterology — Payments: $9,692
Christopher Ko, M.d, M.D
Gastroenterology — Payments: $7,071